Ulcerative Colitis Treatment in Nagpur

Types and Extent of Ulcerative Colitis

Ulcerative Proctitis (20-30%)

Limited to the rectum causing rectal bleeding, urgency, and tenesmus (painful straining). Proctitis is the mildest form with best prognosis. Symptoms often respond to topical therapies and mild systemic therapy. Colonoscopic surveillance still necessary for cancer risk.

Left-Sided Colitis (40-50%)

Involves rectum and colon up to the splenic flexure causing bloody diarrhea and left-sided cramping. More aggressive inflammation than proctitis requiring systemic therapy. Moderate disease activity typically present at diagnosis.

Pancolitis (Universal Colitis – 20-30%)

Affects entire colon causing severe diarrhea, bleeding, systemic symptoms, and toxic megacolon risk. Most severe form requiring aggressive biological therapy. Highest colorectal cancer risk necessitating intensive surveillance.

Ulcerative Colitis Symptoms

• Bloody diarrhea (hallmark symptom)

• Urgency and frequency of bowel movements

• Abdominal pain and cramping

• Tenesmus (painful straining)

• Weight loss and anorexia

• Fever and malaise during flares

• Nocturnal diarrhea disturbing sleep

• Rectal bleeding with mucus passage

• Anemia from chronic blood loss

• Extraintestinal manifestations (joint pain, eye inflammation, skin rashes)

Symptoms fluctuate between remission periods and acute flares. Severe flares cause incapacity requiring hospitalization.

Ulcerative Colitis Causes and Risk Factors

Genetic Predisposition

• Family history (10-15% have affected relatives)

• Multiple susceptibility genes identified

• Increased risk in Ashkenazi Jewish populations

• Concordance in monozygotic twins lower than Crohn’s disease

Environmental Triggers

• Smoking (paradoxically protective – quitting worsens UC)

• Bacterial infections triggering immune response

• Antibiotics disrupting protective microbiota

• High-sugar diet promoting dysbiosis

• Psychological stress exacerbating flares

• Certain medications (NSAIDs)

Immune Dysfunction

• Abnormal intestinal barrier function

• Dysregulated innate immune response

• Altered adaptive immune response

• Impaired mucosal healing capacity

Microbiota Alterations

• Reduced microbial diversity (dysbiosis)

• Decreased beneficial bacteria

• Increased pathogenic organisms

• Compromised intestinal ecosystem balance

Ulcerative Colitis Diagnosis

Clinical Presentation

• Bloody diarrhea for >4 weeks typically

• Continuous symptoms from rectum proximally

• Systemic symptoms assessment

• Family history evaluation

Laboratory Tests

• Inflammatory markers (elevated CRP, ESR)

• Fecal calprotectin (intestinal inflammation marker)

• Complete blood count (anemia assessment)

• Albumin and nutritional markers

• Liver function tests

Imaging Studies

• CT colonography (assesses inflammation extent)

• Plain abdominal radiography (assesses complications)

• Ultrasound (initial screening)

• Flexible sigmoidoscopy (rapid initial diagnosis)

Colonoscopic Evaluation

• Full colonoscopy visualizes entire colon/rectum

• Biopsies confirm diagnosis and assess severity

• Continuous inflammation pattern characteristic

• Surveillance for dysplasia/cancer

Ulcerative Colitis Treatment

Mild-Moderate Disease

5-Aminosalicylates (5-ASA)

• Mesalamine 2.4-4.8 grams daily orally

• Mesalamine enemas for distal disease

• Anti-inflammatory effects proven

• First-line agent for mild-moderate UC

• Maintenance therapy after remission

Corticosteroids (Acute Flares)

• Prednisone 40-60 mg daily tapering

• Rapid symptom improvement

• Not suitable for maintenance therapy

• Taper to discontinuation avoiding dependence

• Alternative: Budesonide for distal disease

Moderate-Severe Disease

Immunomodulators

• Azathioprine: Steroid-sparing therapy

• 6-Mercaptopurine: Alternative immunosuppression

• Delayed onset requiring 6-12 weeks

• Useful in steroid-dependent patients

Biological Agents

• TNF-alpha inhibitors (infliximab, adalimumab)

• Vedolizumab (integrin antagonist)

• Ustekinumab (IL-12/IL-23 inhibitor)

• 60-70% remission rates in severe UC

• Most effective modern agents

Severe Fulminant Disease

• IV corticosteroids (methylprednisolone)

• Cyclosporine or infliximab

• Hospitalization and ICU monitoring

• Surgical consultation if no response (colectomy)

Topical Therapy (Distal Disease)

• Mesalamine enemas or suppositories

• Hydrocortisone enemas for inflammation

• Daily application for symptom control

• Particularly effective for proctitis/left-sided disease

Dietary and Lifestyle Support

• High-calorie diet during remission

• Elemental diet during acute flares

• Vitamin supplementation (B12, folate, iron)

• Fat-soluble vitamins (A, D, E, K)

• Zinc supplementation if deficient

• Avoid trigger foods (high-fat, high-fiber during flares)

• Smoking cessation essential

Ulcerative Colitis Complications

• Toxic megacolon: Acute colonic dilation (emergency)

• Perforation: Colon rupture requiring emergency surgery

• Severe hemorrhage: Life-threatening bleeding

• Colorectal cancer: 20-30 times increased risk

• Primary sclerosing cholangitis: Bile duct inflammation

• Extraintestinal manifestations: Arthritis, uveitis, skin disease

• Anemia: Chronic blood loss

• Protein malnutrition: From chronic diarrhea

• Dehydration and electrolyte imbalance: Severe flares

Ulcerative Colitis Surveillance and Monitoring

Clinical Monitoring

• Monthly visits during active disease

• Every 3 months on maintenance therapy

• Assessment of disease activity and symptoms

• Medication tolerance evaluation

Colonoscopic Surveillance

• Baseline colonoscopy at diagnosis with biopsies

• Repeat colonoscopy 1-2 years post-treatment

• Annual colonoscopy if extensive colitis

• More frequent if dysplasia detected

• Cancer screening critical after 8 years disease duration

Cancer Screening Protocol

• Pancolitis: Annual colonoscopy after 8 years

• Left-sided colitis: Colonoscopy every 1-2 years after 15 years

• Proctitis: Colonoscopy every 5 years after 20 years

• Enhanced surveillance if primary sclerosing cholangitis

Ulcerative Colitis Remission Maintenance

• Medication adherence: Essential for preventing flares

• Smoking cessation: Critical for disease control

• Stress management: Reduces flare frequency

• Regular monitoring: Early detection of complications

• Dietary vigilance: Avoid identified personal triggers

• Immunizations: Keep current before biologic therapy

• Colonoscopic surveillance: Prevent cancer complications